OpenVSafe by OpenVAERS
Search V-safe

C5Y-26591-62455

2 vaccinations 4 coded responses 21 check-ins 4 free-text entries 2 call cases
Sex
Male
Age at first dose
61-65
ZIP prefix
711 / LA
Registered
2021-01-24
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-24
    Registered in v-safe
  2. 2021-01-24
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-24
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-25
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good · Fatigue or tiredness, Diarrhea
    Free text: no
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-31
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-07
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-11
    Dose 2 — Pfizer-BioNTech
  11. 2021-02-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Fatigue, Pyrexia — Feeling: Fair · Site: Redness · Headache, Muscle or body aches, Nausea · Be unable to do your normal daily activities
    Free text: first day ran temp of 101.3. fatigue.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Redness · Joint pains, Muscle or body aches, Nausea
    Adult check-in
  13. 2021-02-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Joint pains, Muscle or body aches
    Adult check-in
  14. 2021-02-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Muscle or body aches
    Adult check-in
  15. 2021-02-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-02-18
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-02-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-03-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-03-11
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-03-18
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-25
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-13
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-08-12
    Survey response — 6 months, dose 2
    MedDRA: Increased viscosity of bronchial secretion, Office visit, Sinusitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: had 3 week sinus infection with thick, tenacious sputum. Treated with Amoxicillin · Healthcare visit (other): Internal Med Dr (b)(6)
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  24. 2021-08-12
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-08-19
  26. 2021-08-19
    Call successful
    Does not wish to fill out VAERS report
  27. 2022-02-11
    Survey response — 12 months, dose 2
    MedDRA: Adverse reaction, Asthenia, Dyspnoea, Fungal infection, Laryngitis, Office visit, SARS-CoV-2 test negative, Sinusitis, Staphylococcal infection, Submaxillary gland enlargement — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: had sinus infection from mid Oct until early Feb. Took multiple antibiotics to get under control. Staph and yeast. swollen sub max glands, laryngitis, SOB, energy loss, 3 neg COVID tests tetracycline TID finally cleared infection. · Healthcare visit (other): internal med had been treating ssx. went to ENT in Jan who changed meds, CT Scan, cultures to find appropriate antibiotic
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-02-11
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  29. 2022-02-15
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-01-24Pfizer-BioNTech
22021-02-11Pfizer-BioNTech

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-25

Systemic reaction (other): no

Release 4 — days 1–6 daily, dose 2

2021-02-13

Systemic reaction (other): first day ran temp of 101.3. fatigue.

Release 9 — 6 months, dose 2

2021-08-12

Symptoms: had 3 week sinus infection with thick, tenacious sputum. Treated with Amoxicillin
Healthcare visit (other): Internal Med Dr (b)(6)
redacted (b)(6)

Release 11 — 12 months, dose 2

2022-02-11

Symptoms: had sinus infection from mid Oct until early Feb. Took multiple antibiotics to get under control. Staph and yeast. swollen sub max glands, laryngitis, SOB, energy loss, 3 neg COVID tests tetracycline TID finally cleared infection.
Healthcare visit (other): internal med had been treating ssx. went to ENT in Jan who changed meds, CT Scan, cultures to find appropriate antibiotic

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOAdverse reaction · · ✓
HCVOOffice visit ✓ · ✓
SDAsthenia · · ✓
SDDyspnoea · · ✓
SDFungal infection · · ✓
SDIncreased viscosity of bronchial secretion ✓ · ✓
SDLaryngitis · · ✓
SDSARS-CoV-2 test negative · · ✓
SDSinusitis ✓ · ✓
SDStaphylococcal infection · · ✓
SDSubmaxillary gland enlargement · · ✓
SROFatigue ✓ ✓ ✓
SRONo adverse event ✓ ✓ ✓
SROPyrexia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release